Roy AM - Search Results

1

Deep learning-accelerated computational framework based on Physics Informed Neural Network for the solution of linear elasticity.

Roy AM, Bose R, Sundararaghavan V, Arróyave R. Roy AM, et al. Neural Netw. 2023 May;162:472-489. doi: 10.1016/j.neunet.2023.03.014. Epub 2023 Mar 13. Neural Netw. 2023. PMID: 36966712

2

An efficient and robust Phonocardiography (PCG)-based Valvular Heart Diseases (VHD) detection framework using Vision Transformer (ViT).

Jamil S, Roy AM. Jamil S, et al. Among authors: roy am. Comput Biol Med. 2023 May;158:106734. doi: 10.1016/j.compbiomed.2023.106734. Epub 2023 Mar 2. Comput Biol Med. 2023. PMID: 36989745

3

The role of lidocaine in cancer progression and patient survival.

Chida K, Kanazawa H, Kinoshita H, Roy AM, Hakamada K, Takabe K. Chida K, et al. Among authors: roy am. Pharmacol Ther. 2024 May 1:108654. doi: 10.1016/j.pharmthera.2024.108654. Online ahead of print. Pharmacol Ther. 2024. PMID: 38701900 Review.

4

CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.

Sato T, Oshi M, Huang JL, Chida K, Roy AM, Endo I, Takabe K. Sato T, et al. Among authors: roy am. Res Sq [Preprint]. 2024 Mar 27:rs.3.rs-4148608. doi: 10.21203/rs.3.rs-4148608/v1. Res Sq. 2024. PMID: 38585981 Free PMC article. Preprint.

5

Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer.

Oshi M, Roy AM, Yan L, Kinoshita S, Tamura Y, Kosaka T, Akiyama H, Kunisaki C, Takabe K, Endo I. Oshi M, et al. Among authors: roy am. Cancer Gene Ther. 2024 Mar 26. doi: 10.1038/s41417-024-00756-w. Online ahead of print. Cancer Gene Ther. 2024. PMID: 38532115

6

SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice.

Willett JDS, Gravel A, Dubuc I, Gudimard L, Dos Santos Pereira Andrade AC, Lacasse É, Fortin P, Liu JL, Cervantes JA, Galvez JH, Djambazian HHV, Zwaig M, Roy AM, Lee S, Chen SH, Ragoussis J, Flamand L. Willett JDS, et al. Among authors: roy am. Commun Biol. 2024 Feb 16;7(1):191. doi: 10.1038/s42003-024-05878-3. Commun Biol. 2024. PMID: 38365933 Free PMC article.

7

Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes.

Chida K, Oshi M, An N, Kanazawa H, Roy AM, Mann GK, Yan L, Endo I, Hakamada K, Takabe K. Chida K, et al. Among authors: roy am. Am J Cancer Res. 2024 Jan 15;14(1):355-367. doi: 10.62347/NCIM3072. eCollection 2024. Am J Cancer Res. 2024. PMID: 38323295 Free PMC article.

8

A 47-Year-Old Woman with Confusion and Weakness.

Patel A, Roy AM, Alberico R, Gandhi S. Patel A, et al. Among authors: roy am. NEJM Evid. 2023 Oct;2(10):EVIDmr2300176. doi: 10.1056/EVIDmr2300176. Epub 2023 Sep 26. NEJM Evid. 2023. PMID: 38320182

9

Higher Inflammatory Response in Hepatocellular Carcinoma is Associated with Immune Cell Infiltration and a Better Outcome.

Oshi M, Chida K, Roy AM, Mann GK, An N, Yan L, Endo I, Takabe K. Oshi M, et al. Among authors: roy am. Res Sq [Preprint]. 2024 Jan 3:rs.3.rs-3768964. doi: 10.21203/rs.3.rs-3768964/v1. Res Sq. 2024. PMID: 38260290 Free PMC article. Preprint.

10

Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?

Alaklabi S, Roy AM, Chaudhary LN, Gandhi S. Alaklabi S, et al. Among authors: roy am. Explor Target Antitumor Ther. 2023;4(6):1301-1309. doi: 10.37349/etat.2023.00198. Epub 2023 Dec 27. Explor Target Antitumor Ther. 2023. PMID: 38213539 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page